Delivery Order SPE2DR25D1100-SPE2DR26FDB4P
Award Date 1/23/26
Potential Completion Date 1/26/26
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $7,575.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat bacterial skin infections. The contract, awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, represents a small-value order fulfilling immediate pharmaceutical supply needs for federal medical operations. The award was made on a non-set-aside, competitive basis to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,850.46 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dalvance 500 mg vials, an antibiotic medication used to treat bacterial skin infections. This firm fixed price delivery order is set to be completed by January 6, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis without any set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $29,398.41 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat bacterial infections. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...
- The Defense Logistics Agency awarded a $58,815.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance (dalbavancin), an antibiotic used to treat bacterial skin infections. The award, issued January 12, 2026, with completion targeted for January 13, 2026, represents a non-competitive delivery order executed under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $5,377.68 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used to treat bacterial skin infections. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive, non-set-aside purchase. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $4,481.35 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials on April 22, 2025, with a completion date of April 23, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,426.25 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, a specialty antibiotic medication. This competitively awarded, firm fixed-price delivery order was issued on July 17, 2025, with an ultimate completion date of July 18, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,854.30 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic pharmaceutical product. This firm fixed price delivery order, issued December 5, 2025, is due for completion by December 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Dalvance 500 mg vials, a specialty antibiotic medication. This firm fixed-price delivery order, valued at $9,459.06, is scheduled for completion by December 29, 2025, with performance taking place at the company's Conshohocken, Pennsylvania facility. The award was made through open competition without any set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,732.44 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used in hospital and clinical settings. This competitively awarded, firm fixed-price delivery order was issued on September 10, 2025, with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...